An investment fund for the commercialisation of health and bio-technologies has been launched in South Australia. The Adelaide China Biotech Investment Fund, launched on December 10, will use $45 million in funding to take research out of the labs at the University of Adelaide, the University of South Australia, and other research institutions and manufacture … Continue reading Foreign investment targets SA biotech sector
A partnership between the University of Sydney and medical manufacturer Codex Research has secured $851,000 of Commonwealth funding through the Innovative Manufacturing Collaborative Research Centre (IMCRC). The project hopes to improve the treatment of heart disease through creating a physiologically-relevant blood vessel implant, that would be used in bypass surgery. Currently, similar products are created … Continue reading Innovative partnership leads to blood vessel manufacture
The University of Melbourne’s new purpose-built biosciences facility is boosting Victoria’s bioscience research and biotechnology capabilities. Minister for Higher Education Gayle Tierney visited the university’s Parkville campus to tour the new Western Edge Biosciences facility on March 25. Bioscience remains one of Victoria’s key strengths within the research and tertiary education sector. “The Western Edge … Continue reading New biosciences facility boosts research opportunities in Victoria
The Queensland government has announced the extension of the Johnson & Johnson Innovation Partnering Office at Queensland University of Technology (QUT), which supports the commericalisation of health technology research. Queensland premier Annastacia Palaszczuk made the announcement as delegates gathered in Brisbane for the AusBiotech National Conference. The state government is providing funding for the office … Continue reading Johnson & Johnson research and development hub extended in Qld
A new collaboration between mineral exploration company, Archer, and the University of Adelaide will seek to develop and implement graphene and carbon-based materials for use in complex biosensing, targeting applications in human health. The project, undertaken as part of the Industrial Transformation Research Hubs scheme, will utilise Archer’s graphite and graphene materials to develop generic … Continue reading Research opens new doors for biosensor technologies
Australian biotech company CSL chose Switzerland over Australia for its new manufacturing plant because of this country’s higher company tax rate, according to the company’s director.
Cochlear has announced a full-year profit 29 per cent lower than 2013’s, but a strong second-half result saw share prices rise to a 12-month high.
Australian biotechnology firm Starpharma has received Therapeutic Goods Administration approval for its anti-viral gel technology.
The government should introduce an incentive to keep intellectual property in Australia once it reaches commercialisation, according to a biotech group.
The Productivity Commission will today release the preliminary report of its inquiry into Australian automotive manufacturing industries.
The project builds on innovative technology in nanofibre manufacturing recently developed by researchers from Cytomatrix and Deakin University.
A Brisbane-based manufacturer has proposed a new incentive for companies that manufacture locally products for which they own or have licensed the patent.